The thin line between cell-penetrating and antimicrobial peptides: The case of Pep-1 and Pep-1-K

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 335-341

  Bobone, Sara ^a   Piazzon, Alessandro ^a   Orioni, Barbara ^a   Pedersen, Jens Z ^a   Nan, Yong Hai ^b   Hahm, Kyung Soo ^b,c   Shin, Song Yub ^b,c   Stella, Lorenzo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Chosun University   (South Korea)

^c Chosun University College of Medicine   (South Korea)

Author keywords

Fluorescence spectroscopy; Ion leakage; Liposomes; Water membrane partition

Indexed keywords

PEPTIDE DERIVATIVE; PEPTIDE PEP 1; PEPTIDE PEP 1 K; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; LIPID BILAYERS; LIPOSOMES; MICROSCOPY, CONFOCAL; SPECTROMETRY, FLUORESCENCE;

BACTERIA (MICROORGANISMS);

EID: 79953780955     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1340     Document Type: Article

References (41)

1. Castanho MARB. Membrane-active Peptides: Methods and Results on Structure and Function. International University Line: La Jolla, CA, 2009.
2. Steiner H, Hultmark D, Engström A, Bennich H, Boman HG. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 1981; 292: 246-248.
3. Selsted ME, Brown DM, DeLange RJ, Lehrer RI. Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J. Biol. Chem. 1983; 258: 11485-14489.
4. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 5449-5454.
5. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009; 30: 131-141.
6. Auvynet C, Rosenstein Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J. 2009; 276: 6497-6508.
7. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
8. Bocchinfuso G, Palleschi A, Orioni B, Grande G, Formaggio F, Toniolo C, Park Y, Hahm KS, Stella L. Different mechanisms of action of antimicrobial peptides: insights from fluorescence spectroscopy experiments and molecular dynamics simulations. J. Pept. Sci. 2009; 15: 550-558.
9. Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau HU, Jacobsen F, Al-Benna S. Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?. Int. J. Mol. Sci. 2009; 10: 3951-3970.
10. Pathan FK, Venkata DA, Panguluri SK. Recent patents on antimicrobial peptides. Recent Pat. DNA Gene Seq. 2010; 4: 10-16.
11. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55: 1189-1193.
12. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 1864-1868.
13. Langel Ü. Handbook of Cell Penetrating Peptides. CRC Press: Oxford, 2006.
14. Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009; 157: 195-206.
15. Foerg C, Merkle HP. On the biomedical promise of cell penetrating peptides: limits versus prospects. J. Pharm. Sci. 2008; 97: 144-162.
16. Henriques ST, Melo MN, Castanho MARB. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem. J. 2006; 399: 1-7.
17. Nekhotiaeva N, Elmquist A, Kuttuva Rajarao G, Hällbrink M, Langel Ü, Good L. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 2004; 18: 394-396.
18. Palm C, Netzereab S, Hällbrink M. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 2006; 27: 1710-1716.
19. Yandek LE, Pokorny A, Florén A, Knoelke K, Langel Ü, Almeida PFF. Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. Biophys. J. 2007; 92: 2434-2444.
20. Thorén PEG, Persson D, Lincoln P, Nordén B. Membrane destabilizing properties of cell-penetrating peptides. Biophys. Chem. 2005; 114: 169-179.
21. Mishra A, Gordon VD, Yang L, Coridan R, Wong GCL. HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. Angew. Chem. Int. Ed. 2008; 47: 2986-2989.
22. Zhu WL, Shin SY. Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. J. Pept. Sci. 2009; 15: 345-352.
23. Ciobanasu C, Siebrasse JP, Kubitscheck U. Cell-penetrating HIV1 TAT peptides can generate pores in model membranes. Biophys. J. 2010; 99: 153-162.
24. Zhu WL, Shin SY. Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its Lys-linked two-stranded peptide. Chem. Biol. Drug Des. 2009; 73: 209-215.
25. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998; 244: 253-257.
26. Nicolas P. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J. 2009; 276: 6483-6496.
27. Takeshima K, Chikushi A, Lee K-K, Yonehara S, Matsuzaki K. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 2003; 278: 1310-1315.
28. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotech. 2001; 19: 1173-1176.
29. Henriques ST, Castanho MARB, Pattenden LK, Aguilar M. Fast membrane association is a crucial factor in the peptide Pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance. Biopolymers (Pept. Sci.) 2010; 94: 314-322.
30. Muñoz-Morris MA, Heitz F, Divita G, Morris MC. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes. Biochem. Biophys. Res. Commun. 2007; 355: 877-882.
31. Deshayes S, Plénat T, Charnet P, Divita G, Molle G, Heitz F. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration. Biochim. Biophys. Acta 2006; 1758: 1846-1851.
32. Henriques ST, Castanho MARB. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity. J. Pept. Sci. 2008; 14: 482-487.
33. Zhu WL, Lan H, Park I-S, Kim JI, Jin HZ, Hahm K-S, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochim. Biophys. Res. Commun. 2006; 349: 769-774.
34. Park N, Yamanaka K, Tran D, Chandrangsu P, Akers JC, de Leon JC, Morrissette NS, Selsted ME, Tan M. The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J. Antimicrob. Chemother. 2009; 63: 115-123.
35. Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980; 104: 10-14.
36. Chattopadhyay A, London E. Parallax method for direct measurement of membrane penetration depth utilizing fluorescence quenching by spin-labeled phospholipids. Biochemistry 1987; 26: 39-45.
37. Stella L, Pallottini V, Moreno S, Leoni S, De Maria F, Turella P, Federici G, Fabrini R, Dawood KF, Lo Bello M, Pedersen JZ, Ricci G. Electrostatic association of glutathione transferase to the nuclear membrane. Evidence of an enzyme defense barrier at the nuclear envelope. J. Biol. Chem. 2007; 282: 6372-6379.
38. Stella L, Venanzi M, Hahm KS, Formaggio F, Toniolo C, Pispisa B. Shining a light on peptide-lipid interactions. Fluorescence methods in the study of membrane-active peptides. Chem. Today 2008; 26: 44-46.
39. Henriques ST, Castanho MARB. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide Pep-1 in lipidic vesicles. Biochemistry 2004; 43: 9716-9724.
40. Orioni B, Bocchinfuso G, Kim JY, Palleschi A, Grande G, Bobone S, Park Y, Kim JI, Hahm KS, Stella L. Membrane perturbation by the antimicrobial peptide PMAP-23: a fluorescence and molecular dynamics study. Biochim. Biophys. Acta 2009; 1788: 1523-1533.
41. Melo MN, Ferre R, Castanho MARB. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 2009; 7: 245-250.